1. |
Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet, 2002, 360(9333): 586.
|
2. |
Weed DL, Hursting SD. Biologic plausibility in causal inference: current method and practice. Am J Epidemiol, 1998, 147(5): 415-425.
|
3. |
Weed DL. Interpreting epidemiological evidence: how meta-analysis and causal inference methods are related. Int J Epidemiol, 2000, 29(3): 387-390.
|
4. |
Mignini LE, Latthe PM, Villar J, et al. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol, 2005, 105(2): 411-425.
|
5. |
Mignini LE, Villar J, Khan KS. Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol, 2006, 194(2): 317-321.
|
6. |
Carter RE, Woolson RF. Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside. J Transl Med, 2004, 2(1): 37.
|
7. |
Petticrew M. Systematic reviews from astronomy to zoology: myths and misconceptions. BMJ, 2001, 322(7278): 98-101.
|
8. |
Chalmers I, Glasziou P. Systematic reviews and research waste. Lancet, 2016, 387(10014): 122-123.
|
9. |
Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense. Syst Rev, 2012, 1: 7.
|
10. |
Green S, Higgins JPT. Preparing a Cochrane review. In Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions (Version 5.1. 0). The Cochrane Collaboration, 2011. Available at: www.Cochranehandbook.org.
|
11. |
Light RJ, Pillemer DB. Summing up: the science of reviewing research. 1985.
|
12. |
De Vries RBM, Hooijmans CR, Langendam MW, et al. A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies. Evid based Precl Med, 2015, 2(1): 1-9.
|
13. |
CAMARADES. Protocols. Available at: http://www.dcn.ed.ac.uk/camarades/research.html#protocols.
|
14. |
SYRCLE. Protocols. Available at: https://www.radboudumc.nl/en/research/departments/health-evidence/systematic-review-centerfor-laboratory-animal-experimentation/protocols.
|
15. |
张婷, 胡凯燕, 张维益, 等. 动物实验系统评价在 PROSPERO 的注册现状及注册流程简介. 中国循证心血管医学杂志, 2019, 11(4): 391-394.
|
16. |
PROSPERO. Centre for Reviews and Dissemination. York: University of York. Available at http://www.crd.york.ac.uk/PROSPERO/.
|
17. |
Macleod M, Howells D. Protocols for laboratory research. Evid based Precl Med, 2016, 3(2): 28-29.
|
18. |
Kilkenny C, Parsons N, Kadyszewski E, et al. Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One, 2009, 4(11): e7824.
|
19. |
Macleod MR, O'Collins T, Howells DW, et al. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke, 2004, 35(5): 1203-1208.
|
20. |
Hooijmans CR, Rovers MM, de Vries RB, et al. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol, 2014, 14: 43.
|
21. |
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions (Version 5.1.0). The Cochrane Collaboration, 2011. Available at: http://www.cochrane-handbook.org.
|
22. |
Kilkenny C, Browne WJ, Cuthi I, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Vet Clin Pathol, 2012, 41(1): 27-31.
|
23. |
Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res, 2018, 27(5): 1171-1179.
|
24. |
National Heart Lung and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services. Study quality assessment tools: Quality assessment tool for observational cohort and cross‐sectional studies. Available at: https://www.nhlbi.nih.gov/health‐topics/study‐quality‐assessment‐tools.
|
25. |
Albers GW, Bogousslavsky J, Bozik MA, et al. Stroke therapy academic industry roundtableⅡ (STAIR-Ⅱ), writing committee. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke, 2001, 32(7): 1598.
|
26. |
Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One, 2010, 5(3): e9810.
|
27. |
Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA, 2002, 287(21): 2831-2834.
|
28. |
Moher D, Booth A, Stewart L. How to reduce unnecessary duplication: use PROSPERO. BJOG, 2014, 121(7): 784-786.
|
29. |
Sideri S, Papageorgiou SN, Eliades T. Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. J Clin Epidemiol, 2018, 100: 103-110.
|
30. |
Ma B, Xu JK, Wu WJ, et al. Survey of basic medical researchers on the awareness of animal experimental designs and reporting standards in China. PLoS One, 2017, 12(4): e0174530.
|
31. |
Kaplan RM, Irvin VL. Likelihood of null effects of large NHLBI clinical trials has increased over time. PLoS One, 2015, 10(8): e0132382.
|
32. |
Heinl C, Chmielewska J, Olevska A, et al. Rethinking the incentive system in science: animal study registries: Preregistering experiments using animals could greatly improve transparency and reliability of biomedical studies and improve animal welfare. EMBO Rep, 2020, 21(1): e49709.
|
33. |
PLoS Medicine Editors. Best practice in systematic reviews: the importance of protocols and registration. PLoS Med, 2011, 8(2): e1001009.
|
34. |
Schiavo JH. PROSPERO: An international register of systematic review protocols. Med Ref Serv Q, 2019, 38(2): 171-180.
|
35. |
Grey P, Grey A, Bolland MJ. Outcomes, interventions and funding in randomised research published in high-impact journals. Trials, 2018, 19(1): 592.
|
36. |
Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol, 2015, 65(10): 963-972.
|
37. |
Zeymer U, Hochadel M, Thiele H, et al. Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. EuroIntervention, 2015, 11(3): 280-285.
|
38. |
周为文, 葛龙, 徐俊峰, 等. 《中国循证医学杂志》发表的干预类系统评价/Meta 分析报告质量评价. 中国循证医学杂志, 2013, 13(4): 482-488.
|
39. |
许家科, 赵璐璐, 廖绪亮, 等. 循证构建动物实验系统评价制作流程. 中国循证医学杂志, 2017, 17(11): 1357-1364.
|
40. |
Peters JL, Sutton AJ, Jones DR, et al. A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B, 2006, 41(7): 1245-1258.
|
41. |
赵霏, 唐晓宇, 寇城坤, 等. 动物实验系统评价/Meta 分析的质量和报告特征. 中国循证医学杂志, 2018, 18(8): 871-877.
|
42. |
牛军强, 王亚楠, 朱芊各, 等. 动物实验方法学和报告质量评估工具的横断面研究. 中国循证医学杂志, 2015, 15(2): 223-229.
|
43. |
Rombey T, Doni K, Hoffmann F, et al. More systematic reviews were registered in PROSPERO each year, but few records' status was up-to-date. J Clin Epidemiol, 2020, 117: 60-67.
|